MediPal Holdings Corporation
7459.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.97 | 1.99 | 0.31 | 0.63 |
| FCF Yield | 10.62% | 8.65% | 0.70% | 10.01% |
| EV / EBITDA | 2.41 | 2.82 | 2.26 | 2.93 |
| Quality | ||||
| ROIC | 4.57% | 4.14% | 4.57% | 4.27% |
| Gross Margin | 6.60% | 6.93% | 6.68% | 6.61% |
| Cash Conversion Ratio | 1.50 | 1.49 | 0.23 | 1.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.00% | 2.64% | 1.52% | 0.39% |
| Free Cash Flow Growth | 21.79% | 1,506.66% | -93.76% | 125.45% |
| Safety | ||||
| Net Debt / EBITDA | -2.70 | -2.47 | -2.21 | -2.97 |
| Interest Coverage | 7,944.43 | 5,916.38 | 1,440.35 | 2,851.50 |
| Efficiency | ||||
| Inventory Turnover | 19.25 | 19.25 | 18.49 | 19.30 |
| Cash Conversion Cycle | 2.25 | 1.67 | 2.63 | -2.83 |